Impact of obesity on disease-modifying therapies (DMTs) response and IL-17 mRNA in patients with Multiple Sclerosis in relation to its phenotypic features - Egyptian Knowledge Bank - troweb

360758

Impact of obesity on disease-modifying therapies (DMTs) response and IL-17 mRNA in patients with Multiple Sclerosis in relation to its phenotypic features

Article

Last updated: 01 Jan 2025

Overview Similar Items

Article

Dyslipidemia in patients with Multiple Sclerosis and its correlation with disease parameters

Article

Association Of Obesity With Relapsing Remitting Multiple Sclerosis Disability In Zagazig University Hospitals.

Article

Disability status among multiple sclerosis patients in relation to clinical features and switched drugs

Article

Impact of multiple sclerosis on quality of patient's life

Article

The Effect of Increased Body Mass Index on Disease Parameters, Quality of Life and Damage Index in Patients with Systemic Lupus Erythematosus

Article

Multiple Sclerosis and Vitamin D: Is there a Link in the Multifactorial Model?

Article

Obesity among Rheumatoid Arthritis Patients and its Relation to Disease Activity: Cross-sectional Study among the Egyptian Population

Article

Assessment of Body Composition in Patients with Multiple Sclerosis: Institutional-Based Cross-Sectional Study

Article

Relation between Obesity, Insulin Resistance and T2DM: Review Article

Article

Factors affecting prognosis in patients with relapsing remitting multiple sclerosis